Shari Gustin
Optometrist · Webster, NYNPI 1740219948
Payments from drug & device makers
Across 131 payments — averaging $65.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$5K
- Sun Pharmaceutical Industries Inc.$578
- Bausch & Lomb Americas Inc.$569
- Sight Sciences, Inc.$510
- Coopervision Inc.$451
- Glaukos Corporation$248
- plus $1K from 15 others
What the payments were for
- Speaking & faculty fees$4,47552%
- Food & beverage$4,14848%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 20 | $4,839 |
| Sun Pharmaceutical Industries Inc. | 13 | $578 |
| Bausch & Lomb Americas Inc. | 19 | $569 |
| Sight Sciences, Inc. | 6 | $510 |
| Coopervision Inc. | 16 | $451 |
| Glaukos Corporation | 2 | $248 |
| Johnson & Johnson Vision Care, Inc. | 12 | $235 |
| Tarsus Pharmaceuticals, Inc. | 7 | $195 |
| Biotissue Holdings Inc. | 2 | $169 |
| Novartis | 9 | $156 |
| Amgen | 1 | $125 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $116 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $88 |
| ABB Con-cise Optical Group LLC | 3 | $80 |
| Menicon America Inc | 3 | $68 |
| AbbVie(2 entities) | 4 | $66 |
| Harrow Eye, LLC | 2 | $37 |
| Shire North American Group Inc | 2 | $37 |
| Thea Pharma Inc. | 1 | $24 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
| Oyster Point Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES$4,475
- CEQUA$324
- KXL System$129
- Photrexa$129
- MIEBO$125
- XIIDRA$125
- TEPEZZA$125
- OMNI$119
- Prokera$112
- AmnioGraft$112
- AmnioGuard$112
- TearCare SmartLid$112
- TEARCARE(TM) (2.2) SYSTEM KIT$112
- TEARCARE SYSTEM$112
How this compares
$8,623 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 23 | $21,447 |
| Travoprost | 27 | $5,805 |
| Timolol Maleate | 48 | $2,840 |
| Latanoprost | 188 | $2,534 |
| Brimonidine Tartrate | 11 | $318 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $120 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $111 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Webster
- Andrew SaccoVestal$1.8M
- George ZikosNew York$1M
- Roy KlineLake Katrine$822K
- Irene FrantzisNew York$663K
- Daphne AmbroseNew York$509K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$384K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Justin BazanBrooklyn$304K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.